Transforming near-patient testing with central lab precision test results in under 5 minutes
In response to the current COVID-19 pandemic, Prominex is accelerating its plans for a rapid SARS-CoV-2 test on its Validex point-of-care molecular diagnostic platform.
“We are committed to providing a near-patient solution in the fight against COVID-19. Validex has the potential to deliver accurate results in 5 minutes aiding healthcare professionals with efficient treatment and infection control decisions.”
-Paul Thomas, CEO